These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21497454)

  • 21. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
    Stinchcombe TE; Morris DE; Moore DT; Bechtel JH; Halle JS; Mears A; Deschesne K; Rosenman JG; Socinski MA
    Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located.
    Zhao L; Chen M; Ten Haken R; Chetty I; Chapet O; Hayman JA; Kong FM
    Radiother Oncol; 2007 Feb; 82(2):153-9. PubMed ID: 17287040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
    Yorke ED; Jackson A; Rosenzweig KE; Braban L; Leibel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):672-82. PubMed ID: 15939548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of induction chemotherapy on estimated risk of radiation pneumonitis in bulky non-small cell lung cancer.
    Amin NP; Miften M; Thornton D; Ryan N; Kavanagh B; Gaspar LE
    Med Dosim; 2013; 38(3):320-6. PubMed ID: 23611631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer.
    Parashar B; Edwards A; Mehta R; Pasmantier M; Wernicke AG; Sabbas A; Kerestez RS; Nori D; Chao KS
    Am J Clin Oncol; 2011 Apr; 34(2):160-4. PubMed ID: 20498591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
    Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer.
    Tucker SL; Jin H; Wei X; Wang S; Martel MK; Komaki R; Liu HH; Mohan R; Chen Y; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):691-8. PubMed ID: 19836159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of geometrical uncertainties on 3D CRT and IMRT dose distributions for lung cancer treatment.
    Schwarz M; Van der Geer J; Van Herk M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1260-9. PubMed ID: 16798418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Three-dimensional conformal radiotherapy for locoregionally recurrent non-small cell lung cancer after initial radiotherapy].
    Wang YJ; Wang LH; Lü JM; Zhao LJ; Xiao ZF; Zhang HX; Feng QF; Zhang Z; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):227-9. PubMed ID: 16875613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study of whether radiation pneumonitis is influenced by low-dose irradiated lung volume in primary lung cancer with chronic pulmonary disease.
    Niibe Y; Hayakawa K; Masuda N; Yoshimura H
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):213-6. PubMed ID: 17301529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
    Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
    J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].
    Ren H; Wang LH; Wang XZ; Lü JM; Ji W; Zhou ZM; Ou GF; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):143-7. PubMed ID: 19538894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose coverage beyond the gross tumor volume for various stereotactic body radiotherapy planning techniques reporting similar control rates for stage I non-small-cell lung cancer.
    Arvidson NB; Mehta MP; Tomé WA
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1597-603. PubMed ID: 19028283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer.
    Rengan R; Rosenzweig KE; Venkatraman E; Koutcher LA; Fox JL; Nayak R; Amols H; Yorke E; Jackson A; Ling CC; Leibel SA
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):741-7. PubMed ID: 15465190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data.
    Bradley JD; Hope A; El Naqa I; Apte A; Lindsay PE; Bosch W; Matthews J; Sause W; Graham MV; Deasy JO;
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):985-92. PubMed ID: 17689035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.
    Jin H; Tucker SL; Liu HH; Wei X; Yom SS; Wang S; Komaki R; Chen Y; Martel MK; Mohan R; Cox JD; Liao Z
    Radiother Oncol; 2009 Jun; 91(3):427-32. PubMed ID: 18937989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of tumor motion characteristics between early stage and locally advanced stage lung cancers.
    Yu ZH; Lin SH; Balter P; Zhang L; Dong L
    Radiother Oncol; 2012 Jul; 104(1):33-8. PubMed ID: 22677039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.
    Seppenwoolde Y; Lebesque JV; de Jaeger K; Belderbos JS; Boersma LJ; Schilstra C; Henning GT; Hayman JA; Martel MK; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):724-35. PubMed ID: 12573760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Impact of diabetes mellitus on clinicopathological factors and relation with radiation pneumonitis in 332 patients with lung cancer].
    Zhou H; Cao K; Cao P; Jiang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Feb; 38(2):138-41. PubMed ID: 23456072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.